Skip to main content
Clinical Interventions in Aging logoLink to Clinical Interventions in Aging
. 2008 Sep;3(3):561–566. doi: 10.2147/cia.s2497

Attitudes toward menopause in HIV-infected and at-risk women

Diana Hartel 1,, Yungtai Lo 1, Carolyn Bauer 2, Nancy Budner 1, Andrea A Howard 1, Michelle Floris-Moore 1, Julia H Arnsten 1,2, Nanette Santoro 3, Ellie E Schoenbaum 1,2,3
PMCID: PMC2682388  PMID: 18982926

Abstract

Objective

To study attitudes toward menopause in women with or at risk of human immunodeficiency virus (HIV) aged 35 to 60 in New York City, NY, USA.

Design

Data were obtained at the baseline interview in a cohort study of menopause. Of 502 participating women, 92 were postmenopausal and 162 were perimenopausal.

Results

Overall, 37.5% of women had a relatively favorable attitude toward menopause. African Americans had a 72% greater odds of a positive attitude (OR = 1.72, 95% CI 1.16–2.57) than all other groups after adjusting for covariates. Hispanic women had the least favorable view of menopause. Experience of >3 menopausal symptoms and negative life events—being a witness to a murder, and the death of a child—were significantly associated with negative attitudes towards menopause (OR = 0.62, 95% CI 0.42–0.93 and OR = 0.64, 95% CI 0.43–0.93, respectively). Depressive symptoms, street drug use, and having a domestic partner, which is significant in single variable analyses, did not remain independent predictors in multivariate results. HIV status, menopause status, and age at interview were not associated with menopause attitudes.

Conclusions

HIV-infected, drug-using, low-income women showed generally unfavorable attitudes towards menopause. High stress life events coupled with a high prevalence of depressive symptoms indicate this population has special needs marked by the menopause transition into older age.

Keywords: menopause, attitudes, HIV, street drug users

Introduction

The menopause marks a major biological transition in the lives of all women with potentially deep psychological and socioeconomic changes (Avis and McKinlay 1991). Attitudinal aspects of the menopause transition have been studied for several decades starting with studies by Neugarten and colleagues (1963). However, most studies of mid-life and menopause attitudes have systematically excluded women with serious illness, disability, or substance abuse.

As the human immunodeficiency virus (HIV) epidemic enters its third decade, a high percentage of women with HIV will also be entering menopause, their lives extended by improvements in antiretroviral therapies, ie, Highly Active Anti-Retroviral Therapy (HAART) (Palella et al 1998). Examination of the literature provides little insight into how women with HIV/acquired immunodeficiency syndrome (AIDS) or who use street drugs for long periods may experience the menopause transition.

We assessed attitudes towards menopause in an impoverished, urban population of midlife women with and at-risk for HIV infection. We hypothesized that HIV and street drug use would be associated with a less positive attitude toward menopause than for the HIV-uninfected women in our study who did not use drugs. We felt it equally plausible that menopause was just one more, relatively minor stressor among the many difficult circumstances among women with HIV as has been suggested by a number of investigators regarding HIV itself (Nyamathi 1992; Ward 1993).

Methods

Sample

As previously described (Schoenbaum et al 2005), a total of 620 women participated in the “Natural History of Menopause in HIV-Infected Women” (Ms Study). Overall enrollment was guided to produce a study with balanced numbers of HIV-infected and uninfected women and with half of the women in the HIV-infected and uninfected groups having a history of heroin or cocaine use in the past five years. This study utilizes data gathered during the enrollment phase with ascertainment of menopause status with 12 months of amenorrhea postbaseline for those in the menopausal transition at time of interview.

Definition of menopause, perimenopause, and menopausal symptoms

Natural menopause was defined according to the World Health Organization (WHO 1996) as at least 12 consecutive months of amenorrhea not due to surgery or other obvious cause, such as extreme weight loss. Perimenopause was defined as absence of menses in at least 3 cycles but no more than 11 during the past 12 months. For this analysis we did not distinguish between early and late perimenopause due to small numbers of women in the perimenopause. Menopausal symptoms were classified into six groups, vasomotor, genitourinary, musculoskeletal, weight gain, palpitations, and insomnia and excluded psychological symptoms which were ubiquitous in the population (Miller et al 2005).

Dependent variable

A modified version of the Neugarten Attitudes Toward Menopause (ATM), a 35-item questionnaire, was administered as part of the baseline Ms interview. For each item on the ATM, women were asked to indicate if they agreed strongly, agreed somewhat, disagreed somewhat, or disagreed strongly or could not agree or disagree (don’t know). Since the original Neugarten ATM was not designed for populations such as ours, a panel of 17 women familiar with the study population (primarily experienced research interviewers) selected a subset of ATM items. A 65% agreement was required by the panel in order to include an item. The items intended for middle-class, married women in the 1960s were dropped as inappropriate to a sample with an extensive history of street drug use and who are largely without partners. For example, we dropped: “After menopause, a woman gets more interested in activities outside the home.” In the end we used 27 items (15 negative items, and 12 positive items) taken from the original ATM. Negative items were reverse coded for summation with positive items. Using this modified questionnaire, we condensed scores to a simple agree, don’t know, or disagree code similar to scoring used for attitude items in the Study of Women Across the Nation (SWAN) (Sommer et al 1999). We examined variables in relation to average score and also to scores above 2, indicating more positive attitude, compared to those 2 and lower

Exclusions

Of the 620 women originally enrolled in Ms, women who had a hysterectomy and/or bi-lateral oophorectomy prior to entering the perimenopause (n = 22) were excluded. In addition, 24 women taking hormones for the symptoms of menopause during perimenopause within 6 months of interview were also excluded due to an inability to properly classify their status. Fifty-six women responding “don’t know” more than 25% of the time on the ATM were dropped from analysis. Based on responses to questions on menopause symptoms, we found high nonresponse on the attitudes portion of the study instrument was likely to indicate lack of interest rather than simple lack of knowledge. A further 16 participants were excluded for incomplete or missing data. After the above exclusions, 502 women comprised the sample for this analysis.

Statistical methods

Bivariate analysis of baseline characteristics was performed using chi-square, Fishers’ exact test, ANOVA, Spearman correlation, or Wilcoxon rank tests as appropriate. Multiple logistic regression models were used to identify factors independently associated with an average score above 2 compared with 2 or lower. Variables examined included age and age2, race/ethnicity, education, marital status, HIV status, CD4 + cell count, HAART treatment, drug and alcohol use, menopause status, menopause symptoms, parity, body mass index (BMI), negative life events, and depressive symptoms. Women were classed as having depressive symptoms if Center for Epidemiologic Studies Short Depression Scale (CES-D) scores ≥23 as we have done in previous studies (Moore et al 1999; Schoenbaum et al 2005). Data were analyzed using Stata 9.0 (College Station, TX).

Results

Among the 502 women, 260 (51.8%) were HIV-seropositive, and 92 women (18.3%) were postmenopausal. For HIV-positive, median CD4 count was 455.5 cells/m3 with an interquartile range (IQR) of 274–682. Sixty-four percent (168/261) were maintained on HAART at that time. The median age at interview was 43 (IQR: 40–46) with 27.3% reported using heroin and/or cocaine at the time of interview. The sample included 48.6% African American, 40.2% Hispanic, 9% non-Hispanic white, and 2.2% “other”, which included mixed race.

The overall average attitude toward menopause score (scores from 1 most negative to 3 most positive) was 1.93 with IQR of 1.77–2.10. Among 502 women, 37.5% (188/502) had an average score >2 showing a relatively favorable attitude toward menopause. We found no differences in attitude toward menopause by HIV infection status: 37.3% of the 260 HIV-seropositive women and 37.6% of the 242 seronegative women had scores indicating a positive attitude toward menopause. There were no associations between CD4 count or use of HAART with menopause attitude among those with HIV. African American women showed the most positive attitudes toward menopause compared with all other race or ethnic groups (Table 1). Women reporting a current domestic partner (married or common-law) were less likely to have a positive attitude toward menopause than those with no partner (32.1% vs. 41.3%, p = 0.035).

Table 1.

Single variable associations with attitudes toward menopause score* in (N = 502) women enrolled in Menopause Study (Ms)

n (%) Mean score % Positive attitude p-value*
Age at baseline 0.757
 35–44 253 (50.4) 1.93 39.1
 45–49 179 (35.7) 1.89 34.6
 50–54 49 (9.8) 1.98 36.7
 55+ 21 (4.2) 2.00 42.9
Race/Ethnicity 0.002
 African American 244 (48.6) 1.97 44.3
 Hispanic 202 (40.2) 1.89 29.7
 White 45 (9.0) 1.91 37.8
 Other 11 (2.2) 1.83 27.3
Education (years) 0.498
 ≤11 218 (43.4) 1.90 35.8
 12+ 284 (56.6) 1.94 38.7
Marital status 0.035
 Has partner 209 (41.6) 1.89 32.1
 No partner 293 (58.4) 1.95 41.3
Menopause status 0.912
 Menopause 92 (18.3) 1.94 39.1
 Perimenopause 162 (32.3) 1.93 36.4
 Premenopause 248 (49.4) 1.91 37.5
Menopause symptoms at baseline 0.002
 0–3 symptoms 311 (62.0) 1.95 42.8 0.332
 >3 symptoms 191 (38.0) 1.89 28.8
Parity (number of livebirths)
 None 59 (11.8) 1.92 39.0
  1–2 201 (40.0) 1.96 41.8
  3–4 170 (33.9) 1.90 34.1
  5+ 72 (14.3) 1.90 31.9
Body mass index (BMI) 0.604
 <18.5 (underweight) 7 (1.4) 2.01 57.1
 18.5–24.9 (normal) 126 (25.1) 1.93 38.9
 25–29.9 (overweight) 144 (28.7) 1.94 38.9
 ≥3 (obese) 224 (44.7) 1.91 35.3
HIV infection status 0.945
 HIV-positive 260 (51.8) 1.93 37.3
 HIV-negative 242 (48.2) 1.92 37.6
CESD Score 0.037
 ≥23 195 (38.8) 1.88 31.8
 <23 307 (61.2) 1.96 41.0
Witness to murder 0.034
 Yes 134 (26.7) 1.88 30.0
 No 368 (73.3) 1.94 40.2
Abused as child 0.092
 Yes 211 (42.0) 1.90 33.2
 No 291 (58.0) 1.96 40.6
Molested as child 0.671
 Yes 181 (36.1) 1.92 38.7
 No 321 (63.9) 1.93 36.8
Raped as adult 0.730
 Yes 230 (45.8) 1.92 38.3
 No 272 (54.2) 1.93 36.8
Attacked as adult 0.940
 Yes 298 (59.4) 1.93 37.6
 No 204 (40.6) 1.92 37.3
Death of a child 0.035
 Yes 105 (20.9) 1.88 28.6
 No 397 (79.1) 1.94 39.8
Current drug user (cocaine/heroin) 0.072
 User 137 (27.3) 1.96 43.8
 Nonuser 365 (72.7) 1.91 35.1
Currently in methadone program 0.206
 Yes 175 (34.9) 1.90 33.7
 No 327 (65.1) 1.94 39.5
Problem drinking (any CAGE symptoms) 0.087
 Yes 269 (53.6) 1.94 40.9
 No 233 (46.4) 1.90 33.5
Current cigarette smoker 0.549
 Smoker 339 (67.5) 1.92 38.4
 Nonsmoker 163 (32.5) 1.93 35.6
*

Note: Chi-squared.

Abbreviations: CES-D, Center for Epidemiologic Studies Short Depression Scale.

Reproductive and medical history

Menopause symptoms, but not menopause status, showed an inverse relationship with menopause attitude when women had more than 3 symptoms of any kind (p = 0.002) as shown in Table 1. Single menopause symptoms, such as hot flashes, were not associated with attitude score.

Depressive symptoms and negative life events

Depressive symptoms based on the CESD were related to a more negative menopause attitude score (p = 0.037). High rates of traumatic events were found among our participants: 42% abused as children and 36.1% molested as children, 45.8% raped and 59.4% assaulted as adults. In addition, 26.7% witnessed murder and 19.6% suffered a child’s death. Witness to murder and death of a child showed a statistically significant difference in menopause attitude (Table 1).

Drug and alcohol use

For women reporting current use of heroin and/or cocaine in any form or route within 6 months of baseline interview, a somewhat more positive view of menopause was shown compared with nonusers (43.8% vs. 35.1%, p = 0.072). There was a similar result for problem drinking based on the CAGE screening instrument. Enrollment in methadone and cigarette smoking were not associated with attitudes toward menopause.

Multivariate results

African Americans showed 72% greater odds of a positive attitude (ORadj = 1.72, 95% CI 1.16–2.57) than all other race or ethnic groups while adjusting for the other variables in this model (Table 2). Experience of >3 menopausal symptoms and negative life events—being a witness to a murder, and the death of a child—were significantly associated with negative attitudes towards menopause (OR = 0.62, 95% CI 0.42–0.93 and OR = 0.64, 95% CI 0.43–0.93, respectively). Depressive symptoms, street drug use, and having a domestic partner, which was significant in single variable analyses, did not remain independent predictors in multivariate results. HIV status, menopause status, and age at interview were not associated with menopause attitudes. Age, age2, and menopause status were examined in all models but dropped in the final model due to consistent lack of association.

Table 2.

Multiple logistic regression: Independent predictors of positive attitude toward menopause

Variable Adjusted odds ratio 95% confidence interval p-value
Race/ethnicity
 African American 1.718 1.156–2.566 0.007
 White 1.353 0.685–2.670 0.384
 Hispanic Reference
 Death events* 0.635 0.432–0.933 0.021
 Menopause
 Symptoms >3 0.622 0.418–0.925 0.019
*

Note: Death of a child or witness to murder.

Discussion

The most prominent finding in our study is the overall low level of women expressing a positive attitude (37.5% positive, with 1.93 overall mean score) toward menopause in this impoverished population with a high prevalence of HIV. In contrast, the SWAN study (Sommer et al 1999) enrolled an ethnically diverse population and reported an overall mean “on the positive side of neutral.” A comparable result in our population would be an overall average above 2.00; in fact, it was infrequent to observe average scores above two on most subcategories of variables examined in our study as shown in Table 1. Similar to SWAN, Wilbur and colleagues (1995) showed an overall nonnegative, largely neutral attitude toward menopause in a small, random and diverse sample of women. Since these studies do not use identical menopause attitude items, we do not compare actual overall mean results.

Our study population differs from others as it has the lowest educational levels (43% not completing high school), severe stressors including homelessness, street drug use and addiction, and adverse life events such as witness to murder, sexual abuse and rape. These factors probably colored overall attitudes toward their lives in general.

Menopause status and symptoms

Contrary to studies showing postmenopausal status associated with positive attitudes toward menopause (Neugarten et al 1963; Wilbur et al 1995; Sommer et al 1999), our postmenopausal women did not demonstrate more positive attitudes than peri- or premenopausal women. However, having more than 3 symptoms of menopause was associated with more negative menopause attitude in our data, suggesting that symptoms may outweigh menopause status. The SWAN study found physical symptoms associated with attitudes, however these symptoms were not independent of menopause status in multivariate models. The role of symptoms in menopause can be complex in our population. Many of our study participants experience a wide range of conditions such as tuberculosis, HIV-related symptoms, and drug withdrawal that can overlap or closely resemble some symptoms of menopause. In our investigation of this issue, we found that women did not mis-attribute menopause symptoms to other conditions so much as they simply did not associate them with menopause (Johnson et al 2008). For example, 70% attributed hot flashes to menopause and 29% attributed vaginal dryness to menopause. Our study population also differs from others in its high prevalence of early menopause at a median age of 47 (Schoenbaum et al 2005). The observed early menopause is supported in a subsample of the same Ms cohort members in which menopause symptoms are shown at younger ages than the general population (Miller et al 2005). Furthermore, analysis of reproductive hormone patterns in this population has shown that they are consistent with menopause status and support an earlier menopause onset (Santoro et al 2007). This study also confirmed that age and WHO menopause status classifications used in our study were significantly related to follicle stimulating hormone levels.

Demographic results

Consistent with other reports (Pham et al 1997; Sommer et al 1999), African American women had the most positive attitudes toward menopause: 44.3% positive compared with Hispanic women with 29.7% having a positive attitude. The literature shows less consistency for associations with educational attainment (McKinlay et al 1992), although the SWAN found higher education to be related to better attitude after controlling on age, menopause status, and other variables. With over 43% of women not completing high school and the fairly uniform low socioeconomic status of our participants, we found no such association.

Having a domestic partner—especially a supportive partner—has been reported as a factor in a positive attitude towards menopause (Avis et al 2004). A supportive network has similarly been shown to relate to a positive attitude toward the menopausal transition (Rice 2005). Whether married or common-law, having a domestic partner was related to less favorable attitudes toward menopause in our data but only in bivariate analyses.

Stressful life events, depressive symptoms, and HIV infection status

In our previous study (Miller et al 2005) we found that menopause symptoms were associated with depressive symptoms and negative life events; however, we did not find depressive symptoms independently associated with menopause attitudes. Instead, in this study menopause symptoms and negative life events were related to attitude. The literature shows conflicting results on this issue with some reporting increases in depressive symptoms during the menopausal transition (Maartens et al 2002; Bromberger et al 2003; Freeman et al 2004), while others do not (Woods and Mitchell 1997; Rabkin et al 1997; Avis et al 2001).

We found that HIV infection status per se was not associated with menopause attitudes. In other studies, the psychological profile of impoverished women with HIV is more likely shaped by the milieu of poverty or drug problems than by HIV alone (Nyamathi 1992; Ward 1993). This appears to be the case for menopause as well.

Conclusions

For HIV-infected and drug-using women, the menopause transition is likely to be a very different experience than for women living in mainstream culture. Menopause is an important life event that can mark a change into a period of increasing health risk from cardiovascular disease, osteoporosis, and early death. It is notable that these women who once thought they would die of HIV in a short period are now facing menopause amidst the burdens of poverty, multiple high stress events, and age-related chronic disease conditions.

Acknowledgments

We are grateful for the dedicated work of the interviewers and support staff of this study. The Menopause Study (Ms) was funded through National Institute on Drug Abuse grant (RO1 DA13564) and a Center For AIDS Research grant from the National Institute on AIDS and Infectious Diseases Research (A1051519). The authors report no conflicts of interest.

References

  1. Avis N, Assmann S, Kravigtz H, et al. Quality of life in diverse groups of midlife women: assessing the influence of menopause health status and psychosocial and demographic factors. Qual Life Res. 2004;13:933–46. doi: 10.1023/B:QURE.0000025582.91310.9f. [DOI] [PubMed] [Google Scholar]
  2. Avis NE, Crawford S, Stellato R, et al. Longitudinal study of hormone levels and depression among women transitioning through menopause. Climacteric. 2001;4:243–9. [PubMed] [Google Scholar]
  3. Avis NE, McKinlay SM. A longitudinal analysis of women’s attitudes toward the menopuase: results from the Massachusetts Women’s Health Study. Maturitas. 1991;13:65–79. doi: 10.1016/0378-5122(91)90286-y. [DOI] [PubMed] [Google Scholar]
  4. Bromberger J, Harlow S, Avis N, et al. Racial/ethnic differences in the prevalence of depressive symptoms among middle-aged women: the Study of Women’s Health Across the Nation (SWAN) Am J Pub Health. 2004;8:1378–85. doi: 10.2105/ajph.94.8.1378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bromberger JT, Assmann SF, Avis NE, et al. Persistent mood symptoms in a multiethnic community cohort of pre- and perimenopausal women. Am J Epidemiol. 2003;158:347–56. doi: 10.1093/aje/kwg155. [DOI] [PubMed] [Google Scholar]
  6. Freeman EW, Sammel MD, Liu L, et al. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry. 2004;61:62–70. doi: 10.1001/archpsyc.61.1.62. [DOI] [PubMed] [Google Scholar]
  7. Johnson T, Cohen H, Howard A, et al. Attribution of menopause symptoms in HIV-infected or at-risk drug-using women. Menopause. 2008;15:551–7. doi: 10.1097/gme.0b013e31815879df. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Maartens LW, Knottnerus JA, Pop VJ. Menopausal transition and increased depressive symptomatology: a community based prospective study. Maturitas. 2002;42:195–200. doi: 10.1016/s0378-5122(02)00038-5. [DOI] [PubMed] [Google Scholar]
  9. McKinlay S, Brambilla D, Posner J. The normal menopause transition. Maturitas. 1992;14:103–15. doi: 10.1016/0378-5122(92)90003-m. [DOI] [PubMed] [Google Scholar]
  10. Miller SA, Santoro N, Lo Y, et al. Menopause symptoms in HIV-infected and drug using women. Menopause. 2005;2:348–56. doi: 10.1097/01.gme.0000141981.88782.38. [DOI] [PubMed] [Google Scholar]
  11. Moore J, Schuman P, Schoenbam E, et al. Severe adverse life events and depressive symptoms among women with, or at risk for, HIV infection in four cities in the United States of America. AIDS. 1999;13:2459–68. doi: 10.1097/00002030-199912030-00018. [DOI] [PubMed] [Google Scholar]
  12. Neugarten BL, Wood V, Kraines RJ, et al. Women’s attitudes toward the menopuase. Vita Humana. 1963;6:140–51. doi: 10.1159/000269714. [DOI] [PubMed] [Google Scholar]
  13. Nyamathi A. Comparative study of factors relating to HIV risk level of black homeless women. JAIDS. 1992;5:222–8. [PubMed] [Google Scholar]
  14. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853–60. doi: 10.1056/NEJM199803263381301. [DOI] [PubMed] [Google Scholar]
  15. Pham KT, Grisso JA, Freeman EW. Ovarian aging and hormone replacement therapy: hormonal levels, symptoms, and attitudes of African-American and white women. J Gen Intern Med. 1997;12:230–6. doi: 10.1046/j.1525-1497.1997.012004230.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Rabkin JG, Johnson J, Lin SH, et al. Psychopathology in male and female HIV-positive and negative injecting drug users: longitudinal course over 3 years. AIDS. 1997;11:507–15. doi: 10.1097/00002030-199704000-00015. [DOI] [PubMed] [Google Scholar]
  17. Rice V. Strategies and issues for managing menopause-related symptoms in diverse populations: ethnic and racial diversity. Am J Med. 2005;118(Suppl 2):142–7. doi: 10.1016/j.amjmed.2005.09.048. [DOI] [PubMed] [Google Scholar]
  18. Santoro N, Yungtai L, Moskaleva G, et al. Factors affecting reproductive hormones in HIV-infected, substance-using middle-aged women. Menopause. 2007;15(5):1–7. doi: 10.1097/GME.0b013e31802f7369. [DOI] [PubMed] [Google Scholar]
  19. Schoenbaum EE, Hartel D, Lo Y, et al. HIV Infection, drug use, and onset of natural menopause. Clin Infect Dis. 2005;41:1517–24. doi: 10.1086/497270. [DOI] [PubMed] [Google Scholar]
  20. Sommer B, Avis N, Meyer P, et al. Attitudes toward menopause and aging across ethnic/racial groups. Psychosom Med. 1999;61:868–75. doi: 10.1097/00006842-199911000-00023. [DOI] [PubMed] [Google Scholar]
  21. Ward M. A different disease: HIV/AIDS and health care for women in poverty. Cult Med Psychiatry. 1993;17:413–30. doi: 10.1007/BF01379308. [DOI] [PubMed] [Google Scholar]
  22. Wilbur J, Miller A, Montgomery A. The influence of demographic characteristics, menopausal status, and symptoms on women’s attitudes toward menopause. Women Health. 1995;23:19–39. doi: 10.1300/J013v23n03_02. [DOI] [PubMed] [Google Scholar]
  23. Woods NF, Mitchell ES. Pathways to depressed mood for midlife women: observations from the Seattle Midlife Women’s Health Study. Res Nurs Health. 1997;20:119–29. doi: 10.1002/(sici)1098-240x(199704)20:2<119::aid-nur4>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  24. [WHO] World Health Organization Scientific Group. WHO Technical Services Department Series No. 866. Geneva, Switzerland: WHO; 1996. Research on the menopause in the 1990s. [PubMed] [Google Scholar]

Articles from Clinical Interventions in Aging are provided here courtesy of Dove Press

RESOURCES